Related Podcast

What is MASH?
2025

What Is Resmetirom and How Does It Work to Treat MASH?
2025

Part 3 - Strategies for Educating the APP Community on MASH
2024

Part 2 - Using NITs to Identify and Manage MASH Patients
2024

GHAPPcast: Recognizing the Severity of MASH
2025

Part 1 - Incorporating the Newly Approved Therapy for MASH into Practice
2024

Part 4 - MASH- What We Don't Know, What We Want to Know
2024

How Is MASH Severity Staged? What Would an Ideal MASH NIT Algorithm Look Like?
2025

What Are the Consequences of MASH Going Untreated?
2025

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2025